
Mohammad M. Hoque
Examiner (ID: 9407, Phone: (571)272-6266 , Office: P/2817 )
| Most Active Art Unit | 2817 |
| Art Unit(s) | 2817, 2823 |
| Total Applications | 844 |
| Issued Applications | 653 |
| Pending Applications | 100 |
| Abandoned Applications | 113 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16434819
[patent_doc_number] => 20200352144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => Animal Models and Therapeutic Molecules
[patent_app_type] => utility
[patent_app_number] => 16/870365
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34836
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 321
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16870365
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/870365 | Animal Models and Therapeutic Molecules | May 7, 2020 | Abandoned |
Array
(
[id] => 16481558
[patent_doc_number] => 20200375158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => Animal Models and Therapeutic Molecules
[patent_app_type] => utility
[patent_app_number] => 16/870413
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 454
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16870413
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/870413 | Animal Models and Therapeutic Molecules | May 7, 2020 | Abandoned |
Array
(
[id] => 17704948
[patent_doc_number] => 20220204954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => ENGINEERED CAS9 WITH BROADENED DNA TARGETING RANGE
[patent_app_type] => utility
[patent_app_number] => 17/605932
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605932
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605932 | ENGINEERED CAS9 WITH BROADENED DNA TARGETING RANGE | Apr 23, 2020 | Abandoned |
Array
(
[id] => 18792092
[patent_doc_number] => 11825818
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Method for preparing a large animal model with peritoneal carcinomatosis
[patent_app_type] => utility
[patent_app_number] => 16/846321
[patent_app_country] => US
[patent_app_date] => 2020-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 11
[patent_no_of_words] => 5474
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16846321
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/846321 | Method for preparing a large animal model with peritoneal carcinomatosis | Apr 10, 2020 | Issued |
Array
(
[id] => 17673065
[patent_doc_number] => 20220186232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => GENETICALLY REPROGRAMMED TREGS EXPRESSING CARS
[patent_app_type] => utility
[patent_app_number] => 17/598208
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598208
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/598208 | GENETICALLY REPROGRAMMED TREGS EXPRESSING CARS | Mar 25, 2020 | Pending |
Array
(
[id] => 17911327
[patent_doc_number] => 20220313722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => METHODS OF RESTORING LYSOSOMAL FUNCTION OF RETINAL PIGMENT EPITHELIAL CELLS BY ACTIVATION OF TFEB
[patent_app_type] => utility
[patent_app_number] => 17/640422
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17640422
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/640422 | METHODS OF RESTORING LYSOSOMAL FUNCTION OF RETINAL PIGMENT EPITHELIAL CELLS BY ACTIVATION OF TFEB | Mar 5, 2020 | Pending |
Array
(
[id] => 16343927
[patent_doc_number] => 20200308577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => DNA-RESPONSIVE HYDROGELS, METHODS OF ALTERING A PROPERTY OF A HYDROGEL, AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/778524
[patent_app_country] => US
[patent_app_date] => 2020-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16778524
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/778524 | DNA-RESPONSIVE HYDROGELS, METHODS OF ALTERING A PROPERTY OF A HYDROGEL, AND APPLICATIONS THEREOF | Jan 30, 2020 | Pending |
Array
(
[id] => 16206917
[patent_doc_number] => 20200239907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => P21-Activated Kinase Inhibitor Domain Targeted Transgenic Mouse
[patent_app_type] => utility
[patent_app_number] => 16/775747
[patent_app_country] => US
[patent_app_date] => 2020-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16775747
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/775747 | P21-Activated Kinase Inhibitor Domain Targeted Transgenic Mouse | Jan 28, 2020 | Abandoned |
Array
(
[id] => 16976285
[patent_doc_number] => 20210220522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => HYDROGEL-BASED IMPLANTABLE DEVICE AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 16/744810
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6686
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744810
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/744810 | HYDROGEL-BASED IMPLANTABLE DEVICE AND RELATED METHODS | Jan 15, 2020 | Abandoned |
Array
(
[id] => 16670466
[patent_doc_number] => 20210059229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => ADAM6 KNOCKIN MICE
[patent_app_type] => utility
[patent_app_number] => 16/741513
[patent_app_country] => US
[patent_app_date] => 2020-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16741513
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/741513 | ADAM6 KNOCKIN MICE | Jan 12, 2020 | Abandoned |
Array
(
[id] => 16007331
[patent_doc_number] => 20200178508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => HUMANIZED IL-15 ANIMALS
[patent_app_type] => utility
[patent_app_number] => 16/732400
[patent_app_country] => US
[patent_app_date] => 2020-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16732400
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/732400 | Humanized IL-15 animals | Jan 1, 2020 | Issued |
Array
(
[id] => 15990377
[patent_doc_number] => 20200171059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => MODULATING PHOSPHATASE ACTIVITY IN CARDIAC CELLS
[patent_app_type] => utility
[patent_app_number] => 16/731585
[patent_app_country] => US
[patent_app_date] => 2019-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16731585
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/731585 | MODULATING PHOSPHATASE ACTIVITY IN CARDIAC CELLS | Dec 30, 2019 | Abandoned |
Array
(
[id] => 16106723
[patent_doc_number] => 20200205384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => Transgenic Animals
[patent_app_type] => utility
[patent_app_number] => 16/725707
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16725707
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/725707 | Transgenic Animals | Dec 22, 2019 | Pending |
Array
(
[id] => 16152083
[patent_doc_number] => 20200214274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => CELLS, VERTEBRATES, POPULATIONS & METHODS
[patent_app_type] => utility
[patent_app_number] => 16/721326
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26577
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721326
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/721326 | CELLS, VERTEBRATES, POPULATIONS & METHODS | Dec 18, 2019 | Pending |
Array
(
[id] => 16086937
[patent_doc_number] => 20200197455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => STEM CELL DELIVERED ONCOLYTIC HERPES SIMPLEX VIRUS AND METHODS FOR TREATING BRAIN TUMORS
[patent_app_type] => utility
[patent_app_number] => 16/715293
[patent_app_country] => US
[patent_app_date] => 2019-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16715293
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/715293 | STEM CELL DELIVERED ONCOLYTIC HERPES SIMPLEX VIRUS AND METHODS FOR TREATING BRAIN TUMORS | Dec 15, 2019 | Abandoned |
Array
(
[id] => 19372376
[patent_doc_number] => 12063914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => DNA sequence that increases odorant receptor representation in the olfactory system
[patent_app_type] => utility
[patent_app_number] => 16/704740
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 9387
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16704740
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/704740 | DNA sequence that increases odorant receptor representation in the olfactory system | Dec 4, 2019 | Issued |
Array
(
[id] => 15646891
[patent_doc_number] => 20200085975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => GENE THERAPY FOR TREATING HEMOPHILIA A
[patent_app_type] => utility
[patent_app_number] => 16/691822
[patent_app_country] => US
[patent_app_date] => 2019-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16691822
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/691822 | Gene therapy for treating hemophilia A | Nov 21, 2019 | Issued |
Array
(
[id] => 18102593
[patent_doc_number] => 11542472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Generation of inner ear cells
[patent_app_type] => utility
[patent_app_number] => 16/678990
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 25
[patent_no_of_words] => 13468
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16678990
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/678990 | Generation of inner ear cells | Nov 7, 2019 | Issued |
Array
(
[id] => 17341289
[patent_doc_number] => 20220007620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => ANIMAL MODEL FOR AMPLIFYING HUMAN OR ANIMAL CIRCULATING TUMOR CELLS
[patent_app_type] => utility
[patent_app_number] => 17/289188
[patent_app_country] => US
[patent_app_date] => 2019-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289188
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/289188 | ANIMAL MODEL FOR AMPLIFYING HUMAN OR ANIMAL CIRCULATING TUMOR CELLS | Oct 28, 2019 | Issued |
Array
(
[id] => 15769365
[patent_doc_number] => 20200115700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => METHODS FOR TARGETED INSERTION OF DNA IN GENES
[patent_app_type] => utility
[patent_app_number] => 16/601144
[patent_app_country] => US
[patent_app_date] => 2019-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16601144
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/601144 | METHODS FOR TARGETED INSERTION OF DNA IN GENES | Oct 13, 2019 | Abandoned |